Loading...

Becton, Dickinson and Company

BDXANYSE
HealthcareMedical - Instruments & Supplies
$59.24
$-1.36(-2.24%)

Becton, Dickinson and Company (BDXA) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
4.16%
4.16%
Profit Growth
$5.19
14.89%
EPS Growth
$5.19
18.31%
Operating Margin
11.33%
13.55%
ROE
5.86%
14.89%
Dividend Yield
0.00%
2.44%
Analyst Recommendations data is not available for BDXAAnalyst Recommendations details for BDXA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Founded

2017

Frequently Asked Questions